Mexican Pharmaceutical Forum
Mexican Pharmaceutical Forum
  • EspañolEspañol
  • Home
  • About us
  • Venue
  • Programme
  • Speakers
  • Suggest a speaker
  • Networking
  • Mexican Pharma Awards
    • About the Awards
    • Application for the nomination
  • Sponsorship
  • News
  • Contact us
  • EspañolEspañol
  • Home
  • About us
  • Venue
  • Programme
  • Speakers
  • Suggest a speaker
  • Networking
  • Mexican Pharma Awards
    • About the Awards
    • Application for the nomination
  • Sponsorship
  • News
  • Contact us
Mexico: +52 558 526-60-31
UK: +44 204 577-36-57
mexico@iventu.co.uk
45 Fitzroy Street, Fitzrovia London, W1T 6EB, United Kingdom
Mexican Pharmaceutical Forum
Mexican Pharmaceutical Forum


January 13, 2018

Footer


T-MEC and ‘nearshoring’ can increase exports to the US: Bancomext

0August 25, 20220

Reform advances to facilitate access to naloxone as treatment for opioid overdose

0July 19, 20220

The Ministry of Health and Navy create in Mexico Intelligence Center against Sanitary Risks

0August 3, 20220

Mexico runs out of Vitacillina, five pharmacies report it as “out of stock”, and Internet users claim shortage

0August 10, 20220
Diana Parra y Omar Lugo

UCB Celebrates 25 Years in Mexico and Inaugurates New Offices

0October 18, 20220

AMELAF AMLO AstraZeneca Bayer Becton Dickinson BMS Brazil Bristol Myers Squibb CANIFARMA Cannabis CETIFARMA COFEPRIS Concamin counterfeit drugs COVID-19 DHL Edomex Eli Lily Grisi Hermanos Hernán Porcile INEGI Inflation INSABI Korea Latin America Marzam Monkeypox Naloxone Neolpharma Novartis NTA Paxlovid Pfizer Pharmacy Automation Puebla Sandoz SARS-CoV-2 SEMAR Spain Takeda UNEFARM UNOPS US Vaccines Xebra

  • facebookJoin us on facebook
  • linkedinJoin us on linkedin
  • twitterJoin us on twitter
  • instagramJoin us on instagram

Global Pharmaceutical Leaders' Club

45 Fitzroy Street, Fitzrovia
London, W1T 6EB, United Kingdom

MEXICO +52 558 526-60-31
UK+44 204 577-36-57
Send your inquiry

© 2022 Global Pharmaceutical Leaders' Club Ltd. All rights reserved | Privacy Policy | Terms and Conditions | FAQ